0001567619-22-011902.txt : 20220531 0001567619-22-011902.hdr.sgml : 20220531 20220531123828 ACCESSION NUMBER: 0001567619-22-011902 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220527 FILED AS OF DATE: 20220531 DATE AS OF CHANGE: 20220531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buesinger Robert F. CENTRAL INDEX KEY: 0001488587 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32260 FILM NUMBER: 22981789 MAIL ADDRESS: STREET 1: 2801 POST OAK BLVD, SUITE 600 CITY: HOUSTON STATE: TX ZIP: 77056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WESTLAKE CORP CENTRAL INDEX KEY: 0001262823 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 760346924 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 POST OAK BLVD STREET 2: SUITE 600 CITY: HOUSTON STATE: TX ZIP: 77056 BUSINESS PHONE: 713-960-9111 MAIL ADDRESS: STREET 1: 2801 POST OAK BLVD STREET 2: SUITE 600 CITY: HOUSTON STATE: TX ZIP: 77056 FORMER COMPANY: FORMER CONFORMED NAME: WESTLAKE CHEMICAL CORP DATE OF NAME CHANGE: 20030908 4 1 doc1.xml FORM 4 X0306 4 2022-05-27 0 0001262823 WESTLAKE CORP WLK 0001488587 Buesinger Robert F. 2801 POST OAK BOULEVARD, SUITE 600 HOUSTON TX 77056 0 1 0 0 EVP, HIP, IT & Digital Common Stock 2022-05-27 4 M 0 9571 107.75 A 21351 D Common Stock 2022-05-27 4 M 0 4856 86.5379 A 26207 D Common Stock 2022-05-27 4 S 0 14427 129.467 D 11780 D Employee Option (right to buy) 107.75 2022-05-27 4 M 0 9571 0 D 2028-02-16 Common Stock 9571 0 D Employee Option (right to buy) 86.5379 2022-05-27 4 M 0 4856 0 D 2031-02-19 Common Stock 4856 9862 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $129.45 to $129.72, inclusive. The reporting person undertakes to provide to Westlake Corporation, any security holder of Westlake Chemical Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock options were excercisable in three installments of 33%, 33% and 34% on February 16, 2019, 2020 and 2021, respectively. The stock options were excercisable in three installments of 33%, 33% and 34% on February 19, 2022, 2023 and 2024, respectively. Robert F. Buesinger by J. Feng POA 2022-05-31